Flywheel.io

Multicenter studies at Bristol Myers Squibb require scalable imaging workflows that reduce operational complexity and support reproducible AI-driven research. See how Flywheel helps enterprise biopharma teams centralize imaging operations, standardize datasets, and accelerate imaging AI initiatives at scale.

Bristol Myers Squibb teams are scaling imaging AI initiatives across oncology and neuroscience research, but fragmented imaging workflows can slow progress. Explore Flywheel resources focused on AI-ready datasets, multicenter imaging harmonization, and scalable research infrastructure.

Multicenter studies at Johnson & Johnson require scalable imaging workflows that reduce operational complexity and support reproducible AI-driven research. See how Flywheel helps enterprise biopharma teams centralize imaging operations, standardize datasets, and accelerate imaging AI initiatives at scale.

Your imaging data holds the key to faster trial decisions if your teams can actually access and trust it. Flywheel's validated platform gives researchers centralized, curated, AI-ready imaging data across your multisite oncology, neurology, and immunology programs. See how 10 of the top 20 biopharma companies turn imaging data into faster clinical trial insights.

One talk to add to your BioTechX agenda. Flywheel's Mike Maker will explore how leading pharmaceutical teams can activate imaging data across R&D, from data readiness and endpoint analysis to AI development 📍 BioTechX, Messe Basel 📅 October 7 | 12:05 PM 🎤 The Imaging Data Factory: Activating Imaging Data Across the Full R&D Pipeline

Heading to BioTechX in Basel? Don't miss this one. Join Flywheel's Mike Maker for his talk, “The Imaging Data Factory: Activating Imaging Data Across the Full R&D Pipeline,” and discover how automated imaging pipelines can transform raw, scattered medical imaging data into trusted, AI-ready datasets, accelerating AI development without compromising provenance or compliance. 📅 October 7 | 12:05 PM 📍 BioTechX, Messe Basel Add it to your BioTechX agenda.